Clinical Trial Update: Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

View source ↗

Summary

A UC San Francisco-backed clinical trial is evaluating whether hyperpolarized 13C MRI can predict response to therapy in pancreatic ductal adenocarcinoma, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: University of California, San Francisco | Conditions: Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma | Status: RECRUITING